Redcare Pharmacy (SHPPF) Stock Forecast & Price Target

1 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

SHPPF Analyst Ratings

Strong Buy

7 Buy

1 Hold

0 Sell

Based on 8 analysts giving stock ratings to

Redcare

Pharmacy

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

SHPPF Stock 12 Month Forecast

Average Price Target

$108.71

▲(67.76% Upside)

Based on 8 Wall Street analysts offering 12 month price targets for Redcare Pharmacy in the last 3 months. The average price target is $108.71 with a high forecast of $128.88 and a low forecast of $82.93. The average price target represents a 67.76% change from the last price of $64.80.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"40":"$40","129":"$129","62.25":"$62.3","84.5":"$84.5","106.75":"$106.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":128.87751,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$128.88</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":108.70537800000001,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$108.71</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":82.929876,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$82.93</span>\n  </div></div>","useHTML":true}}],"tickPositions":[40,62.25,84.5,106.75,129],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,61.89,67.04288538461539,72.19577076923076,77.34865615384615,82.50154153846154,87.65442692307693,92.80731230769231,97.96019769230769,103.11308307692308,108.26596846153846,113.41885384615384,118.57173923076923,123.72462461538461,{"y":128.87751,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,61.89,65.49118292307692,69.09236584615385,72.69354876923077,76.29473169230769,79.89591461538461,83.49709753846155,87.09828046153847,90.6994633846154,94.30064630769232,97.90182923076924,101.50301215384616,105.10419507692309,{"y":108.70537800000001,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,61.89,63.508452,65.126904,66.745356,68.36380799999999,69.98226,71.600712,73.21916399999999,74.837616,76.45606799999999,78.07451999999999,79.692972,81.31142399999999,{"y":82.929876,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":89.055,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.2,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.92,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.27,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.506,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.555,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.14,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.98,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.24,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.8,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.8,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.8,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":61.89,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$128.88

Average Price Target$108.71

Lowest Price Target$82.93

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Gerhard Orgonas

Berenberg Bank

$105.34→$114.31

Buy

76.40%

Upside

Reiterated

10/07/26

Redcare Pharmacy (0RJT) Receives a Buy from Berenberg Bank

Volker Bosse

Baader Bank

$95.26

Buy

47.00%

Upside

Reiterated

10/05/26

Baader Bank Remains a Buy on Redcare Pharmacy (0RJT)

Christian Salis

Cantor Fitzgerald

$123.27→$127.76

Buy

97.16%

Upside

Reiterated

09/29/26

Cantor Fitzgerald Reaffirms Their Buy Rating on Redcare Pharmacy (0RJT)

Jan Koch

Deutsche Bank

$115.43→$116.55

Buy

79.86%

Upside

Reiterated

09/29/26

Deutsche Bank Sticks to Its Buy Rating for Redcare Pharmacy (0RJT)

Martin Comtesse

Jefferies

$108.71

Buy

67.76%

Upside

Reiterated

09/28/26

Redcare Pharmacy: Buy Rating Reiterated as German Rx Growth Drives Upgraded FY26 Outlook and $97 Price Target Maintained

Guillaume Galland

Barclays

$95.26

Buy

47.00%

Upside

Assigned

08/12/26

Barclays Reaffirms Their Buy Rating on Redcare Pharmacy (0RJT)

Olivier Calvet

UBS

$67.24→$82.93

Hold

27.98%

Upside

Reiterated

07/31/26

UBS Remains a Hold on Redcare Pharmacy (0RJT)

Yannik Siering

Warburg Research

$128.88

Buy

98.89%

Upside

Reiterated

07/29/26

Redcare Pharmacy (0RJT) Receives a Buy from Warburg Research

Sven Sauer

Kepler Capital

$44.83

Hold

-30.82%

Downside

Reiterated

05/06/26

Kepler Capital Remains a Hold on Redcare Pharmacy (0RJT)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Gerhard Orgonas

Berenberg Bank

$105.34→$114.31

Buy

76.40%

Upside

Reiterated

10/07/26

Redcare Pharmacy (0RJT) Receives a Buy from Berenberg Bank

Volker Bosse

Baader Bank

$95.26

Buy

47.00%

Upside

Reiterated

10/05/26

Baader Bank Remains a Buy on Redcare Pharmacy (0RJT)

Christian Salis

Cantor Fitzgerald

$123.27→$127.76

Buy

97.16%

Upside

Reiterated

09/29/26

Cantor Fitzgerald Reaffirms Their Buy Rating on Redcare Pharmacy (0RJT)

Jan Koch

Deutsche Bank

$115.43→$116.55

Buy

79.86%

Upside

Reiterated

09/29/26

Deutsche Bank Sticks to Its Buy Rating for Redcare Pharmacy (0RJT)

Martin Comtesse

Jefferies

$108.71

Buy

67.76%

Upside

Reiterated

09/28/26

Redcare Pharmacy: Buy Rating Reiterated as German Rx Growth Drives Upgraded FY26 Outlook and $97 Price Target Maintained

Guillaume Galland

Barclays

$95.26

Buy

47.00%

Upside

Assigned

08/12/26

Barclays Reaffirms Their Buy Rating on Redcare Pharmacy (0RJT)

Olivier Calvet

UBS

$67.24→$82.93

Hold

27.98%

Upside

Reiterated

07/31/26

UBS Remains a Hold on Redcare Pharmacy (0RJT)

Yannik Siering

Warburg Research

$128.88

Buy

98.89%

Upside

Reiterated

07/29/26

Redcare Pharmacy (0RJT) Receives a Buy from Warburg Research

Sven Sauer

Kepler Capital

$44.83

Hold

-30.82%

Downside

Reiterated

05/06/26

Kepler Capital Remains a Hold on Redcare Pharmacy (0RJT)

Stocks with the Highest Top Analyst Consensus in the General Sector

STDNStandard Nuclear

SKHYSK Hynix

ITGITG Inc. Class A

LIMENeutron Holdings, Inc.

EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Redcare Pharmacy

3 Months

Christian SalisCantor Fitzgerald

Success Rate

24/33 ratings generated profit

Average Return

+19.86%

Copying Christian Salis's trades and holding each position for 3 Months would result in 72.73% of your transactions generating a profit, with an average return of +19.86% per trade.

1 Year

Christian SalisCantor Fitzgerald

Success Rate

22/33 ratings generated profit

Average Return

+53.04%

Copying Christian Salis's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +53.04% per trade.

2 Years

Christian SalisCantor Fitzgerald

Success Rate

17/33 ratings generated profit

Average Return

+55.03%

Copying Christian Salis's trades and holding each position for 2 Years would result in 51.52% of your transactions generating a profit, with an average return of +55.03% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SHPPF Analyst Recommendation Trends

Rating

Jun 26

Jul 26

Aug 26

Sep 26

Oct 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, SHPPF has received 11 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SHPPF average Analyst price target in the past 3 months is 108.71.

Each month's total comprises the sum of three months' worth of ratings.

SHPPF Financial Forecast

SHPPF Earnings Forecast

Next quarter’s earnings estimate for SHPPF is $0.07 with a range of $0.07 to $0.07. The previous quarter’s EPS was $0.26. SHPPF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year SHPPF has Performed in-line its overall industry.

SHPPF Sales Forecast

Next quarter’s sales forecast for SHPPF is $941.99M with a range of $925.59M to $954.68M. The previous quarter’s sales results were $958.61M. SHPPF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year SHPPF has Performed in-line its overall industry.

SHPPF Stock Forecast FAQ

What is SHPPF’s average 12-month price target, according to analysts?

Based on analyst ratings, Redcare Pharmacy’s 12-month average price target is 108.71.

What is SHPPF’s upside potential, based on the analysts’ average price target?

Redcare Pharmacy has 67.76% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is SHPPF a Buy, Sell or Hold?

Redcare Pharmacy has a consensus rating of Strong Buy which is based on 7 buy ratings, 1 hold ratings and 0 sell ratings.

What is Redcare Pharmacy’s price target?

The average price target for Redcare Pharmacy is 108.71. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $128.88 ,the lowest forecast is $82.93. The average price target represents 67.76% Increase from the current price of $64.8.

What do analysts say about Redcare Pharmacy?

Redcare Pharmacy’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.

How can I buy shares of SHPPF?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Redcare Pharmacy (SHPPF) Stock Forecast & Price Target

SHPPF Analyst Ratings

SHPPF Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Redcare Pharmacy

SHPPF Analyst Recommendation Trends

SHPPF Financial Forecast

SHPPF Earnings Forecast

SHPPF Sales Forecast

SHPPF Stock Forecast FAQ

Detailed List of Analyst Forecasts